NCT04500808View on ClinicalTrials.gov

A Study of Macitentan, in Healthy Japanese Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

December 14, 2020

Conditions
Healthy
Interventions
DRUG

Macitentan Dose 1

Participants will receive Dose 1 of macitentan tablet in Part 1.

DRUG

Macitentan Dose 2

Participants will receive Dose 2 of macitentan tablet in Part 1.

DRUG

Macitentan Dose 3

Participants will receive Dose 2 of macitentan tablet in Part 1 and 2.

DRUG

Placebo

Participants will receive matching placebo from Day 1 up to Day 13.

Trial Locations (1)

130-0004

Sumida Hospital, Tokyo

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY